A dopamine-induced gene expression signature regulates neuronal function and cocaine response.
Katherine E SavellJennifer J TuscherMorgan E ZipperlyCorey G DukeRobert A PhillipsAllison J BaumanSaakshi ThukralFaraz A SultanNicholas A GoskaLara IanovJeremy J DayPublished in: Science advances (2020)
Drugs of abuse elevate dopamine levels in the nucleus accumbens (NAc) and alter transcriptional programs believed to promote long-lasting synaptic and behavioral adaptations. Here, we leveraged single-nucleus RNA-sequencing to generate a comprehensive molecular atlas of cell subtypes in the NAc, defining both sex-specific and cell type-specific responses to acute cocaine experience in a rat model system. Using this transcriptional map, we identified an immediate early gene expression program that is up-regulated following cocaine experience in vivo and dopamine receptor activation in vitro. Multiplexed induction of this gene program with a large-scale CRISPR-dCas9 activation strategy initiated a secondary synapse-centric transcriptional profile, altered striatal physiology in vitro, and enhanced cocaine sensitization in vivo. Together, these results define the transcriptional response to cocaine with cellular precision and demonstrate that drug-responsive gene programs can potentiate both physiological and behavioral adaptations to drugs of abuse.
Keyphrases
- gene expression
- prefrontal cortex
- transcription factor
- single cell
- genome wide
- dna methylation
- drug induced
- genome wide identification
- uric acid
- public health
- quality improvement
- copy number
- genome wide analysis
- liver failure
- high intensity
- parkinson disease
- crispr cas
- bone marrow
- metabolic syndrome
- diabetic rats
- cancer therapy
- oxidative stress
- mesenchymal stem cells
- high glucose
- intimate partner violence
- respiratory failure
- hepatitis b virus
- adverse drug
- electronic health record